Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Sinopia's LEADS® Platform is now open to upgrade its potential with the NIGMS stamp
Date 05 January 2026

Sinopia's LEADS® Platform is now open to upgrade its potential with the NIGMS stamp

Announcement Sinopia Biosciences, Inc., a leading biotechnology company known for modernising novel therapeutics with the help of its exclusive LEADS® drug discovery platform, proudly declared th...

Co-Diagnostics received an Australian trademark, with the official introduction to its robust platform and property
Date 01 January 2026

Co-Diagnostics received an Australian trademark, with the official introduction to its robust platform and property

Announcement Co-Diagnostics, Inc., a leading molecular diagnostics company with a remarkable patented platform for the establishment of molecular diagnostics tests, today proudly announced that it ha...

GE to enter a new era of building a strong healthcare business following Jack Welch's legacy
Date 31 December 2025

GE to enter a new era of building a strong healthcare business following Jack Welch's legacy

Announcement GE Healthcare’s CEO Peter Arduini is molding a new chapter for the overall $20 billion in business gained over the year. GE Healthcare Technologies was first introduced as a standa...

CancerVax's impressive year-end overview boosts confidence
Date 29 December 2025

CancerVax's impressive year-end overview boosts confidence

Milestone CancerVax, Inc., a leading developer of a groundbreaking Universal Cancer Treatment Platform that treats cancer through the body’s immune system, revealed its year end overview, spotl...

Phio takes a lead in its Drug Development Program for PH-762
Date 29 December 2025

Phio takes a lead in its Drug Development Program for PH-762

Announcement Phio Pharmaceuticals Corp., a well-known clinical-level siRNA biopharmaceutical company discovering therapeutics with its exclusive INTASYL® gene mutation technology to treat cancer....

The US Healthcare is again in the limelight now with Trump's favorable deal
Date 24 December 2025

The US Healthcare is again in the limelight now with Trump's favorable deal

Announcement Trump has been in the limelight since its tariffs storm that shook the trading, healthcare and other sectors as well. Recently, Trump has come up with some favourable and convincing deal...

The FDA's guidance and policies made major changes this year
Date 24 December 2025

The FDA's guidance and policies made major changes this year

FDA’s Policy Initiatives The FDA’s guidance and various policies were at a pace this year. Neverthless the guidance on vaccines and rare disease have attracted most of the deals, with pol...

Telo Genomics study lined up for the next year with the University of Athens
Date 23 December 2025

Telo Genomics study lined up for the next year with the University of Athens

Announcement Telo Genomics Corp., a champion in prognostic and diagnostic innovation fueled by advanced telomere analytics, has declared its new efforts for a new multiple myeloma (MM) Minimal Residu...

Xoma's Latest Bet on a Struggling Biotech
Date 19 December 2025

Xoma's Latest Bet on a Struggling Biotech

Announcement Xoma Royalty, a company that has been quietly building a business by acquiring troubled biotech firms, has found its latest target. Late Monday, Xoma announced plans to acquire Generatio...

Pharmanovia's entry with catumaxomab in Germany
Date 18 December 2025

Pharmanovia's entry with catumaxomab in Germany

Announcement Pharmanovia, a leading popular pharmaceutical company that markets the novel speciality drugs and the trusted developed medicines, has now introduced its Korjuny (Catumaxomab) in Germany...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.